NZ597727A - Cell culture medium for adamts protein expression - Google Patents
Cell culture medium for adamts protein expressionInfo
- Publication number
- NZ597727A NZ597727A NZ597727A NZ59772710A NZ597727A NZ 597727 A NZ597727 A NZ 597727A NZ 597727 A NZ597727 A NZ 597727A NZ 59772710 A NZ59772710 A NZ 59772710A NZ 597727 A NZ597727 A NZ 597727A
- Authority
- NZ
- New Zealand
- Prior art keywords
- culture medium
- cell culture
- protein expression
- adamts protein
- adamts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0684—Cells of the urinary tract or kidneys
- C12N5/0686—Kidney cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/24—Metalloendopeptidases (3.4.24)
- C12Y304/24087—ADAMTS13 endopeptidase (3.4.24.87)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/22—Zinc; Zn chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/95—Protein-free medium and culture conditions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/99—Serum-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23047709P | 2009-07-31 | 2009-07-31 | |
PCT/US2010/044020 WO2011014838A1 (en) | 2009-07-31 | 2010-07-30 | Cell culture medium for adamts protein expression |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ597727A true NZ597727A (en) | 2013-08-30 |
Family
ID=42668009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ597727A NZ597727A (en) | 2009-07-31 | 2010-07-30 | Cell culture medium for adamts protein expression |
Country Status (22)
Country | Link |
---|---|
US (7) | US8313926B2 (en) |
EP (1) | EP2459702B1 (en) |
JP (5) | JP5451884B2 (en) |
KR (5) | KR101574056B1 (en) |
CN (2) | CN102549145B (en) |
AU (1) | AU2010278751B2 (en) |
BR (2) | BR122021005965B1 (en) |
CA (1) | CA2769361A1 (en) |
CO (1) | CO6501191A2 (en) |
EA (1) | EA023193B1 (en) |
ES (1) | ES2583258T3 (en) |
HK (1) | HK1171790A1 (en) |
HR (1) | HRP20160783T1 (en) |
HU (1) | HUE029110T2 (en) |
IN (1) | IN2012DN00801A (en) |
MX (2) | MX2012001261A (en) |
NZ (1) | NZ597727A (en) |
PL (1) | PL2459702T3 (en) |
PT (1) | PT2459702T (en) |
SG (1) | SG178194A1 (en) |
SI (1) | SI2459702T1 (en) |
WO (1) | WO2011014838A1 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE029110T2 (en) * | 2009-07-31 | 2017-02-28 | Baxalta GmbH | Cell culture medium for adamts protein expression |
PL3064508T3 (en) | 2010-07-08 | 2020-02-28 | Baxalta GmbH | Method of producing recombinant high molecular weight vwf in cell culture |
PL2837680T3 (en) | 2011-07-01 | 2020-08-10 | Amgen Inc. | Mammalian cell culture |
WO2014062535A1 (en) | 2012-10-15 | 2014-04-24 | Bristol-Myers Squibb Company | Mammalian cell culture processes for protein production |
US9611455B2 (en) | 2013-03-13 | 2017-04-04 | Merck Sharp & Dohme Corp. | Adapted lepidopteran insect cells for the production of recombinant proteins |
US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
AR095196A1 (en) * | 2013-03-15 | 2015-09-30 | Regeneron Pharma | SERUM FREE CELL CULTIVATION MEDIA |
US10138467B2 (en) * | 2013-10-14 | 2018-11-27 | Ares Trading S.A. | Medium for high performance mammalian fed-batch cultures |
AU2015269365A1 (en) | 2014-06-04 | 2016-12-15 | Amgen Inc. | Methods for harvesting mammalian cell cultures |
KR101867134B1 (en) * | 2015-03-23 | 2018-06-12 | 한양대학교 산학협력단 | Cell culture media for production of target material with high yield using mammalian cell, method for culturing cells and production of target material using the cell culture media |
WO2016191169A1 (en) * | 2015-05-22 | 2016-12-01 | Dupont Nutrition Biosciences Aps | Acetolactate decarboxylase |
TWI797060B (en) | 2015-08-04 | 2023-04-01 | 美商再生元醫藥公司 | Taurine supplemented cell culture medium and methods of use |
AU2017307582C1 (en) | 2016-08-04 | 2021-05-06 | Takeda Pharmaceutical Company Limited | Use of adamts13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome |
BR112019009033A2 (en) * | 2016-11-04 | 2019-07-09 | Baxalta GmbH | Adeno-associated virus purification methods |
JP2021515584A (en) * | 2018-03-16 | 2021-06-24 | ジェンザイム・コーポレーション | Methods for improving cell viability in production bioreactors |
CA3103443A1 (en) * | 2018-06-18 | 2019-12-26 | Synthetic Biologics, Inc. | Methods of making alkaline phosphatase agents |
MY190624A (en) | 2019-12-06 | 2022-04-27 | Regeneron Pharma | Anti-vegf protein compositions and methods for producing the same |
WO2021198781A2 (en) | 2020-04-02 | 2021-10-07 | Takeda Pharmaceutical Company Limited | Adamts13 variant, compositions, and uses thereof |
CN115835904A (en) | 2020-05-22 | 2023-03-21 | 武田药品工业有限公司 | ADAMTS13 compositions and methods for the treatment and diagnosis of coronary viral disease complications |
CN111808822B (en) * | 2020-07-02 | 2024-01-12 | 北京百普赛斯生物科技股份有限公司 | Feed supplement liquid for cell culture and method for improving recombinant HEK293 cell protein expression quantity |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
US5250421A (en) | 1986-01-03 | 1993-10-05 | Genetics Institute, Inc. | Method for producing factor VIII:C-type proteins |
JPH0753104B2 (en) * | 1989-02-28 | 1995-06-07 | 秀明 山田 | Bacterial culture method |
CZ280901B6 (en) | 1988-10-06 | 1996-05-15 | Hideaki Yamada | Rhodococcus rhodochrous bacteria cultivation method |
GB9022545D0 (en) | 1990-10-17 | 1990-11-28 | Wellcome Found | Culture medium |
CA2205015C (en) | 1994-11-10 | 2003-04-08 | Otfried Kistner | Method for producing biologicals in protein-free culture |
JP3649249B2 (en) | 1995-02-23 | 2005-05-18 | クエスト・インターナショナル・サービシーズ・ビー・ブイ | Peptides for tissue and cell culture |
US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
EP2243827B2 (en) | 1996-08-30 | 2017-11-22 | Life Technologies Corporation | Serum-free mammalian cell culture medium, and uses thereof |
IT1285158B1 (en) | 1996-09-17 | 1998-06-03 | Angeletti P Ist Richerche Bio | SOLUBLE POLYPEPTIDES WITH THE SERINO-PROTEASIS ACTIVITY OF NS3 OF THE HEPATITIS C VIRUS, AND PROCEDURE FOR THEIR PREPARATION AND |
AU735469B2 (en) | 1996-10-07 | 2001-07-12 | Ascend Performance Materials Llc | Process for the hydroxylation of benzene |
JP4543402B2 (en) | 1996-10-10 | 2010-09-15 | ライフ テクノロジーズ コーポレーション | Animal cell culture medium containing plant-derived nutrients |
US5804420A (en) | 1997-04-18 | 1998-09-08 | Bayer Corporation | Preparation of recombinant Factor VIII in a protein free medium |
AT407255B (en) | 1997-06-20 | 2001-02-26 | Immuno Ag | RECOMBINANT CELL CLONE WITH INCREASED STABILITY IN SERUM- AND PROTEIN-FREE MEDIUM AND METHOD FOR OBTAINING THE STABLE CELL CLONE |
US6475725B1 (en) | 1997-06-20 | 2002-11-05 | Baxter Aktiengesellschaft | Recombinant cell clones having increased stability and methods of making and using the same |
US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
US6406909B1 (en) | 1998-07-10 | 2002-06-18 | Chugai Seiyaku Kabushiki Kaisha | Serum-free medium for culturing animal cells |
AT409379B (en) | 1999-06-02 | 2002-07-25 | Baxter Ag | MEDIUM FOR PROTEIN- AND SERUM-FREE CELL CULTURE |
US6926894B2 (en) | 2000-11-22 | 2005-08-09 | Baxter Aktiengesellschaft | Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV |
AU2003295270A1 (en) | 2002-12-23 | 2004-07-14 | Fuji Photo Film B.V. | Process for coating cell-culture support |
AU2005248299A1 (en) * | 2004-04-16 | 2005-12-08 | Wyeth | ADAMTS-8 proteins and uses thereof |
US20060094104A1 (en) | 2004-10-29 | 2006-05-04 | Leopold Grillberger | Animal protein-free media for cultivation of cells |
JP2007174948A (en) * | 2005-12-27 | 2007-07-12 | Noritsu Koki Co Ltd | Apparatus for producing enzyme water |
JP4880997B2 (en) * | 2005-12-28 | 2012-02-22 | アルフレッサファーマ株式会社 | Method for stabilizing ADAMTS13 |
CN102643777A (en) * | 2006-01-04 | 2012-08-22 | 巴克斯特国际公司 | Oligopeptide-free cell culture media |
BRPI0622214A2 (en) * | 2006-12-22 | 2012-01-03 | Springer Carrier Ltda | Air conditioning unit and Method of mixing air in one air conditioning unit |
US20090067805A1 (en) | 2007-09-10 | 2009-03-12 | Victor Company Of Japan, Limited | Recording and reproducing device |
PL2574677T3 (en) * | 2007-12-27 | 2017-12-29 | Baxalta GmbH | Cell culture processes |
HUE029110T2 (en) * | 2009-07-31 | 2017-02-28 | Baxalta GmbH | Cell culture medium for adamts protein expression |
-
2010
- 2010-07-30 HU HUE10740810A patent/HUE029110T2/en unknown
- 2010-07-30 KR KR1020157009715A patent/KR101574056B1/en active IP Right Grant
- 2010-07-30 KR KR1020127005425A patent/KR101573972B1/en active IP Right Grant
- 2010-07-30 SG SG2012006839A patent/SG178194A1/en unknown
- 2010-07-30 CA CA2769361A patent/CA2769361A1/en not_active Abandoned
- 2010-07-30 WO PCT/US2010/044020 patent/WO2011014838A1/en active Application Filing
- 2010-07-30 KR KR1020157033595A patent/KR101756354B1/en active IP Right Grant
- 2010-07-30 PL PL10740810.6T patent/PL2459702T3/en unknown
- 2010-07-30 EA EA201270224A patent/EA023193B1/en not_active IP Right Cessation
- 2010-07-30 MX MX2012001261A patent/MX2012001261A/en active IP Right Grant
- 2010-07-30 CN CN201080042028.1A patent/CN102549145B/en active Active
- 2010-07-30 CN CN201510186244.8A patent/CN104962539B/en active Active
- 2010-07-30 US US12/847,999 patent/US8313926B2/en active Active
- 2010-07-30 KR KR1020177035177A patent/KR101912552B1/en active IP Right Grant
- 2010-07-30 BR BR122021005965-9A patent/BR122021005965B1/en active IP Right Grant
- 2010-07-30 PT PT107408106T patent/PT2459702T/en unknown
- 2010-07-30 EP EP10740810.6A patent/EP2459702B1/en active Active
- 2010-07-30 JP JP2012523110A patent/JP5451884B2/en active Active
- 2010-07-30 ES ES10740810.6T patent/ES2583258T3/en active Active
- 2010-07-30 BR BR112012002151-6A patent/BR112012002151B1/en active IP Right Grant
- 2010-07-30 AU AU2010278751A patent/AU2010278751B2/en active Active
- 2010-07-30 KR KR1020177018298A patent/KR101808496B1/en active IP Right Grant
- 2010-07-30 NZ NZ597727A patent/NZ597727A/en unknown
- 2010-07-30 IN IN801DEN2012 patent/IN2012DN00801A/en unknown
- 2010-07-30 SI SI201031238A patent/SI2459702T1/en unknown
-
2012
- 2012-01-27 MX MX2013009470A patent/MX344970B/en unknown
- 2012-02-27 CO CO12033821A patent/CO6501191A2/en unknown
- 2012-09-19 US US13/622,939 patent/US8759026B2/en active Active
- 2012-12-06 HK HK12112610.1A patent/HK1171790A1/en unknown
-
2014
- 2014-05-13 US US14/276,819 patent/US9127265B2/en active Active
-
2015
- 2015-07-23 US US14/807,745 patent/US9441216B2/en active Active
-
2016
- 2016-05-06 JP JP2016093240A patent/JP6511007B2/en active Active
- 2016-07-04 HR HRP20160783TT patent/HRP20160783T1/en unknown
- 2016-08-09 US US15/232,626 patent/US10072254B2/en active Active
-
2018
- 2018-01-26 JP JP2018011373A patent/JP6567707B2/en active Active
- 2018-09-08 US US16/125,688 patent/US10724024B2/en active Active
-
2019
- 2019-07-31 JP JP2019141485A patent/JP6883071B2/en active Active
-
2020
- 2020-06-16 US US16/903,185 patent/US11254921B2/en active Active
-
2021
- 2021-05-07 JP JP2021079239A patent/JP7083059B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ597727A (en) | Cell culture medium for adamts protein expression | |
GB2446525A (en) | Stem cell culture medium and method | |
GB2452456A (en) | Cell growth medium | |
WO2009135074A3 (en) | Microorganisms for the production of methacrylic acid | |
SG10201809817UA (en) | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription | |
BRPI0922572A2 (en) | method for culturing pluripotent cells, pluripotent mammalian cell culture, cell culture medium, isolated pluripotent animal cell, and method for increasing pluripotence of a mammalian cell. | |
WO2011133902A3 (en) | Cell culture medium comprising small peptides | |
EP2674487A3 (en) | Large-scale production of soluble hyaluronidase | |
NZ591244A (en) | IDENTIFICATION AND USE OF BACTERIAL [2Fe-2S] DIHYDROXY-ACID DEHYDRATASES | |
DK1495112T3 (en) | Cell Culture Medium | |
NZ603029A (en) | New methods for isolating tr1 cells | |
PT2401383E (en) | Methods for selecting eukaryotic cells expressing a heterologous protein | |
WO2012046065A3 (en) | Culture method for culturing pluripotent cells comprising an inhibitor of mirna- 181a* | |
MX2010005079A (en) | Methods of measuring cell viability without using control cells. | |
EP2480657A4 (en) | Method of efficiently establishing induced pluripotent stem cells | |
MX2010001996A (en) | Cell carrier containing collagen. | |
IL215602A0 (en) | Method for the cultivation of cell population in a serum free medium | |
WO2009044846A1 (en) | Method of predicting drug-induced phospholipidosis | |
MX2010010310A (en) | Method for amplifying locus in bacterial cell. | |
MX2014012407A (en) | Method for increasing the secretion of recombinant proteins. | |
MX2010003555A (en) | Enzymatic methods and enzymes. | |
WO2010097415A3 (en) | Yeast for fructan utilisation | |
UA42324U (en) | Method for raising regeneration ability of callus cultures of soft wheat stable to cultural filtrate of gaeumannomyces graminis var. tritici | |
GB2449001A (en) | Assay for cell culture media and medium supplements | |
NZ730667A (en) | Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 30 JUL 2017 BY COMPUTER PACKAGES INC Effective date: 20140729 |
|
ASS | Change of ownership |
Owner name: BAXALTA GMBH, CH Effective date: 20160414 Owner name: BAXALTA INC, US Effective date: 20160414 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 JUL 2018 BY COMPUTER PACKAGES INC Effective date: 20170701 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 JUL 2019 BY ANAQUA SERVICES Effective date: 20180620 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 JUL 2020 BY ANAQUA SERVICES Effective date: 20190620 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 JUL 2021 BY ANAQUA SERVICES Effective date: 20200622 |
|
ASS | Change of ownership |
Owner name: TAKEDA PHARMACEUTICAL COMPANY, JP Effective date: 20210330 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 JUL 2022 BY ANAQUA SERVICES Effective date: 20210624 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 JUL 2023 BY ANAQUA SERVICES Effective date: 20220621 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 JUL 2024 BY ANAQUA SERVICES Effective date: 20230621 |